What is MERCK Kommanditgesellschaft auf Aktien?
Merck KGaA operates as a science and technology company in Europe, North America, Latin America, Middle East and Africa, and the Asia Pacific.
0O14 · Verdict
Solid reward · low risk
0O14 scores well on cash flow and balance sheet with no major weaknesses flagged in the model.
Based on 75% data coverage
0O14 · Verdict
Top decile vs peers
Current ratio 1.28
9% return on equity
Above average
Model-based scoring. For information only — not financial advice.
Merck KGaA operates as a science and technology company in Europe, North America, Latin America, Middle East and Africa, and the Asia Pacific. The Life Science segment offers products, solutions, and services to academic, research and diagnostic labs, biotech, and pharmaceutical companies, as well as the industrial sector; reagents, consumables, devices, instruments, software, and services for research, production, and testing to lab water instruments, microbiology and biomonitoring products, test assays, analytical reagents, and flow cytometry kits and instruments. The company is listed on the LSE in UK, with a market capitalisation of 24.61B.
The scoring profile indicates moderate reward potential, with profitability and valuation as the leading contributors. Risk indicators are low, suggesting a relatively contained downside profile.
For informational purposes only. Not financial advice.